Log In
BCIQ
Print this Print this
 

Conjumab-A (IN-N01-OX2, N01-OX2)

  Manage Alerts
Collapse Summary General Information
Company Intellect Neurosciences Inc.
DescriptionHumanized IgG4 mAb targeting beta amyloid conjugated to OX2, a small molecule anti-oxidant and protein aggregation inhibitor
Molecular Target
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/08/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today